Saturday 17 October 2026
Export TSHA’s income statement to Excel — free account
Taysha Gene Therapies, Inc.
TSHA Healthcare Biotechnology
Taysha Gene Therapies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.8 million, up 17.3% from fiscal 2024. In the quarter to June 2026, revenue grew 206.8%, EPS fell 44.4%, free cash flow fell 100.3% and total debt rose 20.0%, each against the same quarter a year earlier.
3.62
0.11
−2.95%
Follow TSHA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | — |
+8 more TTM periods Free account |
| (47.05%) | (97.28%) | (68.45%) | (64.93%) | ||
| (37.23%) | (59.21%) | (43.28%) | (40.23%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(34.17%) | (48.35%) | (35.76%) | (35.93%) | |
Average Days of Receivables |
— | — | 0.00 | — | |
Free Cash Flow per Share |
(0.38) | (0.32) | (0.29) | (0.24) | |
Free Cash Flow |
(139.07) | (118.83) | (93.83) | (85.16) | |
Capital Expenditures |
(6.88) | (6.88) | (0.74) | (0.49) | |
| Other line items | |||||
Cash ROIC |
(15.59%) | (22.09%) | (15.20%) | (15.00%) | |
Accounts Receivable Turnover |
— | — | 0.00 | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 732.54% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 287.14% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 112.74% | 0.00% | |
Interest Coverage |
(3,646.64) | (2,501.19) | (1,753.94) | (1,399.04) | |
Operating CF/Net income |
0.88 | 0.86 | 0.85 | 0.85 | |
Depreciation/Fixed assets |
0.49 | 0.18 | 0.17 | 0.17 | |
Capex/Depreciation |
(5.88) | (5.95) | (0.64) | (0.42) | |
Revenue per Share |
0.00 | 0.00 | 0.04 | 0.00 | |
Operating CF per Share |
(0.36) | (0.31) | (0.29) | (0.24) | |
Capex per Share |
(0.02) | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.06 | 0.00 |
Columns are period end dates